528 reports of this reaction
1.4% of all MAGNESIUM CITRATE reports
#9 most reported adverse reaction
DYSPNOEA is the #9 most commonly reported adverse reaction for MAGNESIUM CITRATE, manufactured by CVS Pharmacy, Inc.. There are 528 FDA adverse event reports linking MAGNESIUM CITRATE to DYSPNOEA. This represents approximately 1.4% of all 36,778 adverse event reports for this drug.
Patients taking MAGNESIUM CITRATE who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for MAGNESIUM CITRATE, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for MAGNESIUM CITRATE:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 528 FDA reports for MAGNESIUM CITRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 1.4% of all adverse event reports for MAGNESIUM CITRATE, making it a notable side effect.
If you experience dyspnoea while taking MAGNESIUM CITRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.